Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
Department of Health and Human Services National Institutes of Health
Typ
Research/project funding
Posted on:
Bewerbungsschluss:
Expired
Reference Number
PAR-20-156
This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.
Categories: Health.
Categories: Health.
USA